Assay for asymmetrical dimethyl-l-arginine (adma)

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/34 (2006.01)

Patent

CA 2327413

ADMA is determined in a physiological sample by first removing interfering components: proteins by precipitation; and amines and citrulline, by means of a cation exchange column, followed by enzymatic hydrolysis of the ADMA to citrulline with DDAH. The citrulline is then determined spectrophotometrically.

On détermine la teneur en diméthyl-L-arginine asymétrique (ADMA) d'un échantillon physiologique en éliminant tout d'abord les composants perturbateurs ci-après: les protéines par précipitation ; et les amines et la citrulline au moyen d'une colonne d'échange de cations, puis par hydrolyse enzymatique de la diméthyl-L-arginine asymétrique en citrulline à l'aide de DDAH. On détermine ensuite la teneur en citrulline par spectrophotométrie.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Assay for asymmetrical dimethyl-l-arginine (adma) does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Assay for asymmetrical dimethyl-l-arginine (adma), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Assay for asymmetrical dimethyl-l-arginine (adma) will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2063721

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.